Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,315,584
+$698,561 QoQ
Shares Held
276,653
+54.1% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. ADMA ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ADMA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,315,584 | 276,653 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,617,023 | 179,470 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $7,499,047 | 411,132 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,155,349 | 351,661 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,934,346 | 325,884 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,910,989 | 297,933 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,297,120 | 250,561 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $12,959,016 | 648,275 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $7,166,804 | 641,038 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $605,094 | 91,681 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $362,128 | 80,117 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $715,548 | 199,874 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $908,927 | 246,322 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $739,797 | 223,504 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $25,627 | 6,605 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $29,161 | 12,001 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,165 | 11,195 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,577 | 9,605 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $14,806 | 10,501 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,260 | 10,851 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $21,307 | 13,317 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $59,745 | 33,947 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $349,854 | 179,413 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $403,686 | 168,907 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $506,408 | 172,836 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $372,936 | 129,492 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||